✦ LIBER ✦

Lipid-lowering drugs, cost-effectiveness data, and the formulary system: A health systems perspective

✍ Scribed by John M. Kessler

Book ID: 117011506
Publisher: Elsevier Science
Year: 1999
Tongue: English
Weight: 94 KB
Volume: 137
Category: Article
ISSN: 1097-6744
DOI: 10.1016/s0002-8703(99)70442-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Measuring the cost-effectiveness of lipi

Measuring the cost-effectiveness of lipid-lowering drugs in the elderly:: the outcomes research and economic analysis components of the PROSPER trial

✍ Jerry Avorn; Josh Benner; Ian Ford; David A Ganz; Allan Gaw; Robert J Glynn; Jos 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 227 KB

Cost-effectiveness analysis of rosuvasta

Cost-effectiveness analysis of rosuvastatin versus atorvastatin, simvastatin, and pravastatin from a Canadian health system perspective

✍ Madlaina Costa-Scharplatz; Krishnan Ramanathan; Tony Frial; Bruce Beamer; Sanjay 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 860 KB

Cost-effectiveness of basal insulin from

Cost-effectiveness of basal insulin from a US health system perspective: Comparative analyses of detemir, glargine, and NPH

✍ William J. Valentine; Andrew J. Palmer; Katrina M. Erny-Albrecht; Joshua A. Ray; 📂 Article 📅 2006 🏛 Springer Healthcare Communications 🌐 English ⚖ 215 KB

Comparing two cost-effectiveness studies

Comparing two cost-effectiveness studies of statins for the primary prevention of cardiovascular disease: Are statins cost-effective from a Korean health system perspective?

✍ Haesuk Park; Karen L. Rascati 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 73 KB

PIN50 A Cost-Effectiveness Analysis of T

PIN50 A Cost-Effectiveness Analysis of Telaprevir Versus Boceprevir in the Treatment of Hepatitis C: A Greek National Health System Perspective

✍ J. Yfantopoulos; K. Paparouni; E.R. D'Angelo 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 61 KB

Economics and cost-effectiveness in eval

Economics and cost-effectiveness in evaluating the value of cardiovascular therapies: A health system perspective on thrombolytic therapy for acute myocardial infarction

✍ Christopher A. Lewandowski; John Kahler 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 93 KB